Toronto Dominion Bank’s Cidara Therapeutics CDTX Stock Holding History

Toronto Dominion Bank’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$3.32M	–	2155
2025 Q4	$3.32M	Buy	+15,000	New	+$2.42M	﹤0.01%	960

Toronto Dominion Bank's CDTX Position: Q1 2026 in Review

Toronto Dominion Bank sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 12 shares — an estimated $2.65K sold.

Toronto Dominion Bank first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $2.65K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Toronto Dominion Bank reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Toronto Dominion Bank sold 12 Cidara Therapeutics shares in Q1 2026, an estimated $2.65K.
Toronto Dominion Bank first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Toronto Dominion Bank's Cidara Therapeutics position peaked at $2.65K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.